Literature DB >> 28529780

Hirshfeld analysis and mol-ecular docking with the RDR enzyme of 2-(5-chloro-2-oxoindolin-3-yl-idene)-N-methyl-hydrazinecarbo-thio-amide.

Jecika Maciel Velasques1, Vanessa Carratu Gervini1, Lisliane Kickofel1, Renan Lira de Farias2, Adriano Bof de Oliveira3.   

Abstract

The acetic acid-catalyzed reaction between n class="Chemical">5-chloro-isatin and 4-methyl-thio-semicarbazide yields the title compound, C10H9ClN4OS (I) (common name: 5-chloro-isatin-4-methyl-thio-semicarbazone). The mol-ecule is nearly planar (r.m.s. deviation = 0.047 Å for all non-H atoms), with a maximum deviation of 0.089 (1) Å for the O atom. An S(6) ring motif formed by an intra-molecular N-H⋯O hydrogen bond is observed. In the crystal, mol-ecules are linked by N-H⋯O hydrogen bonds, forming chains propagating along the a-axis direction. The chains are linked by N-H⋯S hydrogen bonds, forming a three-dimensional supra-molecular structure. The three-dimensional framework is reinforced by C-H⋯π inter-actions. The absolute structure of the mol-ecule in the crystal was determined by resonant scattering [Flack parameter = 0.006 (9)]. The crystal structure of the same compound, measured at 100 K, has been reported on previously [Qasem Ali et al. (2012 ▸). Acta Cryst. E68, o964-o965]. The Hirshfeld surface analysis indicates that the most important contributions for the crystal packing are the H⋯H (23.1%), H⋯C (18.4%), H⋯Cl (13.7%), H⋯S (12.0%) and H⋯O (11.3%) inter-actions. A mol-ecular docking evaluation of the title compound with the ribonucleoside diphosphate reductase (RDR) enzyme was carried out. The title compound (I) and the active site of the selected enzyme show Cl⋯H-C(LYS140), Cg(aromatic ring)⋯H-C(SER71), H⋯O-C(GLU200) and FeIII⋯O⋯FeIII inter-molecular inter-actions, which suggests a solid theoretical structure-activity relationship.

Entities:  

Keywords:  Hirshfeld surface analysis; RDR-thio­semicarbazone in silico evaluation; crystal structure; hydrogen bonding; isatin thio­semicarbazone derivative

Year:  2017        PMID: 28529780      PMCID: PMC5418788          DOI: 10.1107/S2056989017005461

Source DB:  PubMed          Journal:  Acta Crystallogr E Crystallogr Commun


Chemical context

Methods for the synthesis of isatin derivatives were first reported in the first half of the 19tn class="Chemical">h century (Erdmann, 1841a ▸,b ▸; Laurent, 1841 ▸), while for thio­semicarbazone derivatives one of the first reports can be traced back to the early 1900’s (Freund & Schander, 1902 ▸). Initially, thio­semi­carbazone chemistry was not related to the pharmacological sciences. This has changed since the discovery that in vitro assays of sulfur-containing compounds showed that they are effective for Mycobacterium tuberculosis growth inhibition (Domagk et al., 1946 ▸). In the 1950’s, the synthesis of isatin–thio­semicarbazone derivatives was reported (Campaigne & Archer, 1952 ▸) and in vitro assays indicated such compounds to be active against Cruzain, Falcipain-2 and Rhodesian (Chiyanzu et al., 2003 ▸). Nowadays, many isatin–thio­semi­carbazone derivatives employed in medicinal chemistry. For example, 1-[(2-methyl­benzimidazol-1-yl) meth­yl]-2-oxo-indo­lin-3-yl­idene]amino]­thio­urea is an in vitro and in silico Chikungunya virus inhibitor (Mishra et al., 2016 ▸). The title compound (I), 5-chloro­isatin-4-methyl­thio­semicarbazone, is an inter­mediate in the synthetic pathway of HIV-1 (human immunodeficiency virus type 1) RT (reverse transcriptase) inhibitor synthesis (Meleddu et al., 2017 ▸); a new crystal structure determination is reported here, the original work having been published by Qasem Ali et al. (2012 ▸). Thus, the crystal structure determination of isatin–thio­semicarbazone-based mol­ecules is an intensive research area in medicinal chemistry and the main focus of our work.

Structural commentary

The present analysis of the title compound (I), measured at 200 K, is very similar to that measured by Qasem Ali et al. (2012 ▸) at 100 K. There is one intra­molecular hydrogen bond, N3—H3N⋯O1 (Table 1 ▸), with an S(6) graph-set motif (Fig. 1 ▸). The mol­ecule is almost planar (r.m.s. deviation = 0.047 Å for all non-H atoms), with maximum deviations of −0.089 (1), −0.073 (1) and 0.057 (1) Å for atoms O1, n class="Gene">Cl1 and S1, respectively. In addition, the torsion angle for the N4—C9—N3—N2 unit is −0.8 (2)°.
Table 1

Hydrogen-bond geometry (Å, °)

Cg is the centroid of the C3–C8 ring.

D—H⋯A D—HH⋯A DA D—H⋯A
N3—H3N⋯O10.83 (2)2.12 (3)2.756 (2)134 (2)
N1—H1N⋯O1i 0.79 (2)2.04 (3)2.824 (2)175 (2)
N4—H4N⋯S1ii 0.88 (3)2.72 (3)3.518 (2)152 (2)
C6—H6⋯Cg iii 0.952.613.410 (2)142

Symmetry codes: (i) ; (ii) ; (iii) .

Figure 1

The mol­ecular structure of the title compound (I) (this work), showing the atom labelling and displacement ellipsoids drawn at the 50% probability level. The intra­molecular hydrogen bond [graph-set motif S(6)] is shown as a dashed line (see Table 1 ▸).

Supra­molecular features

In the crystal, mol­ecules are linked by N1—H1N⋯O1i hydrogen bonds, forming chains propagating along the n class="Species">a-axis direction. The chains are linked by N4—H4N⋯Sii hydrogen bonds, forming a three-dimensional supra­molecular structure (Fig. 2 ▸, Table 1 ▸). The three-dimensional framework is reinforced by C6—H6⋯πiii inter­actions, as shown in Fig. 2 ▸ (see also Table 1 ▸). The crystal structure determined in this work and that of the originally published article (Qasem Ali et al., 2012 ▸) are, of course, similar.
Figure 2

A view along the a axis of the crystal packing of the title compound (I) (this work). Details of the N—H⋯O and N—H⋯S hydrogen bonds (dashed lines) and the C—H⋯π inter­actions (blue arrows) are given in Table 1 ▸. H atoms not involved in these inter­actions have been omitted for clarity.

Hirshfeld surface analysis

The Hirshfeld surface analysis (Hirshn class="Chemical">feld, 1977 ▸) of the crystal structure of (I) suggests that the contribution of the H⋯H inter­molecular inter­actions for the crystal structure cohesion amounts to 23.1%. The contributions of the other major inter­molecular inter­actions are: H⋯C (18.4%), H⋯Cl (13.7%), H⋯S (12.0%) and H⋯O (11.3%). The minor observed contributions for the crystal packing are H⋯N (5.3%) and C⋯N (4.2%). The Hirshfeld surface graphical representation, d norm, with transparency and labelled atoms indicates, in magenta, the locations of the strongest inter­molecular contacts, e.g. the H6 and H2 atoms, which are important for the inter­molecular hydrogen bonding (Fig. 3 ▸ a). The H⋯H, H⋯C, H⋯Cl, H⋯S and H⋯O contributions to the crystal packing are shown as a Hirshfeld surface two-dimensional fingerprint plot with cyan dots. The d e (y axis) and d i (x axis) values are the closest external and inter­nal distances (Å) from given points on the Hirshfeld surface contacts (Figs. 4 ▸ a and 5 ▸) (Wolff et al., 2012 ▸).
Figure 3

The Hirshfeld surface graphical representation (d norm) for the asymmetric unit of: (a) the title compound (I) (this work) and (b) 5-chloro­isatin-thio­semicarbazone (II) (de Bittencourt et al., 2014 ▸). The surface regions with strongest inter­molecular inter­actions are drawn in magenta colour.

Figure 4

Hirshfeld surface two-dimensional fingerprint plots for the crystal structures of: (a) the title compound (I) (this work) and (b) 5-chloro­isatin-thio­semicarbazone (II) (de Bittencourt et al., 2014 ▸), showing the H⋯S contacts in detail (cyan dots). The contribution of the H⋯S inter­actions to the mol­ecular cohesion of the crystal structures amounts to 12.0 and 17.2%, respectively. The d e (y axis) and d i (x axis) values are the closest external and inter­nal distances (Å) from given points on the Hirshfeld surface contacts.

Figure 5

Hirshfeld surface two-dimensional fingerprint plots for the title compound (I) (this work), showing the (a) H⋯H, (b) H⋯C, (c) H⋯Cl and (d) H⋯O contacts in detail (cyan dots). The contributions of the inter­actions to the crystal packing amount to 23.1, 18.4, 13.7 and 11.3%, respectively. The d e (y axis) and d i (x axis) values are the closest external and inter­nal distances (Å) from given points on the Hirshfeld surface contacts.

Mol­ecular docking

Finally, for an inter­action between the 5-chloro­isatin-4-methyl­thio­semicarbazone (this work) and a biological target, the ribonucleoside diphosphate reductase (RDR), a lock-and-key supra­molecular analysis was carried out (Chen, 2015 ▸). The RDR enzyme was selected for this work due its importance in cell prolin class="Chemical">feration. It catalyzes the conversion of ribonucleotides to de­oxy­ribonucleotides, which is the rate-limiting step for DNA synthesis. In addition, a thio­semicarbazone derivative, the 3-amino-pyridine-2-carboxaldehyde thio­semi­carba­zone, shows RDR inhibition and biological activity is suggested by its coordination with the Fe ions of the enzyme active site (Popović-Bijelić et al., 2011 ▸). The commercial name for this thio­semicarbazone derivative is Triapine. Its source until 2009 was Vion Pharmaceuticals Inc., New Haven, CT, United States. Since 2017, Trethera Corporation, Santa Monica, CA, and Nanotherapeutics Inc., Alachua, FL, have had a worldwide agreement for the development, production and commercialization of Triapine formulations and for its applications in hematological malignancies (Nanothera­peutics, 2017 ▸). This illustrates that academic institutions, public and private research facilities and industry have a high level of inter­est in thio­semicarbazone derivatives and in studies concerning RDR–thio­semicarbazone inter­actions. The semi-empirical equilibrium energy of the title compound (this work) was obtained using the PM6 Hamil­tonian (Stewart, 2013 ▸), but the experimental bond lengths were conserved. The crystal structure of the RDR enzyme (PDB code: 1W68) was downloaded from the Protein Data Bank (Strand et al., 2004 ▸). The calculated parameters were: heat of formation = 98.697 kcal mol−1, gradient normal = 0.68005, HOMO = −8.934 eV, LUMO = −1.598 eV and energy gap = 7.336 eV. The title compound (I) and the active site of the selected enzyme matches and structure–activity relationship can be assumed by the following observed inter­molecular inter­actions: Cl1⋯H—C(n class="Chemical">LYS140) = 2.538 Å, Cg(aromatic ring)⋯H—C(SER71) = 2.714 Å, H5⋯O—C(GLU200) = 1.663 Å, Fe1⋯O1 = 2.567 Å and Fe2⋯O1 = 2.511 Å. The in silico evaluation suggests through the graphical representation the bridging O1 atom connecting the two FeIII metal centers by inter­molecular inter­actions (Fig. 6 ▸).
Figure 6

Graphical representation of a lock-and-key model for the title compound (I) (this work) and the RDR enzyme active site, with selected amino acid residues. The inter­actions are shown as dashed lines and the figure in the stick model is simplified for clarity.

Comparison with a related structure

Isatin–thio­semicarbazone derivatives have mol­ecular structural n class="Chemical">features in common, viz. nearly a planar geometry as a result of the sp 2-hybridized C and N atoms of the main fragment. For a comparison with the title compound [5-chloro­isatin-4-methyl­thio­semicarbazone (I); this work], 5-chloro­isatin-thio­semicarbazone, (II), was selected (de Bittencourt et al., 2014 ▸) as both structures have the same main entity. The mol­ecular structural difference is the substitution of one H atom of the amine group of (II) by a methyl group in the title compound (I). Although the mol­ecular basis for the two compounds is the same, there are significant differences in the crystal packing. For compound (I), the unit cell is chiral and the mol­ecules are linked by hydrogen bonding into a three-dimensional network (Figs. 2 ▸ and 7 ▸ a), while for compound (II) the unit cell is centrosymmetric and the hydrogen bonding is observed in a planar arrangement, with the mol­ecules stacked along the [001] direction (Fig. 7 ▸ b). The terminal methyl group in (I) decreases the possibility of H-atom contacts with S and O acceptors, while in compound (II), the presence of the terminal unsubstituted amine increases the chances for hydrogen bonding, as suggested by the Hirshfeld surface analysis, d norm, for the two mol­ecules (Fig. 3 ▸ a,b). The Hirshfeld surface two-dimensional fingerprint plot shows that the contribution of the H⋯S inter­molecular inter­action to the crystal cohesion amounts to 12.0% in the title compound (I), while for the 5-chloro­isatin-thio­semicarbazone (II) it amounts to 17.2% (Fig. 5 ▸ a,b). The relationship between thio­semicarbazone derivatives, the mol­ecular assembly, the geometry of the H⋯S inter­actions and their contribution to the crystal structures can be seen in a recently published article (de Oliveira et al., 2017 ▸).
Figure 7

Section of the crystal structures of: (a) the title compound (I) (this work), and (b) 5-chloro­isatin–thio­semicarbazone (II) (de Bittencourt et al., 2014 ▸), showing the mol­ecular stacking along the [001] direction. The crystal packing of both compounds is viewed along the b axis, and the figures are simplified for clarity.

Synthesis and crystallization

The starting materials are commercially available and were used without further purification. The synthesis of the title compound was adapted from a previously reported procedure (Freund & Schander, 1902 ▸). In an acetic acid-catalyzed reaction, a mixture of n class="Chemical">5-cloroisatin (3 mmol) and 4-methyl-3-thio­semicarbazide (3 mmol) in ethanol (40 ml) was stirred and refluxed for 5 h. On cooling, a solid was obtained which was filtered off. Yellow prismatic crystals of the title compound were grown in tetra­hydro­furan by slow evaporation of the solvent.

Refinement

Crystal data, data collection and structure refinement details for the title compound (I) are summarized in Table 2 ▸. The NH H atoms were located in difn class="Chemical">ference-Fourier maps and freely refined. The C-bound H atoms were positioned with idealized geometry and refined using a riding model: C—H = 0.95–0.98 Å with U iso(H) = 1.5U eq(C-meth­yl) and 1.2U eq(C) for other H atoms. The absolute structure of the mol­ecule in the crystal was determined by resonant scattering [Flack parameter = 0.006 (9)].
Table 2

Experimental details

Crystal data
Chemical formulaC10H9ClN4OS
M r 268.72
Crystal system, space groupOrthorhombic, P212121
Temperature (K)200
a, b, c (Å)6.2584 (1), 10.1734 (2), 18.7183 (3)
V3)1191.78 (4)
Z 4
Radiation typeMo Kα
μ (mm−1)0.48
Crystal size (mm)0.46 × 0.16 × 0.12
 
Data collection
DiffractometerBruker APEXII CCD area detector
Absorption correctionMulti-scan (SADABS; Bruker, 2014)
T min, T max 0.697, 0.749
No. of measured, independent and observed [I > 2σ(I)] reflections10426, 2342, 2295
R int 0.013
(sin θ/λ)max−1)0.617
 
Refinement
R[F 2 > 2σ(F 2)], wR(F 2), S 0.020, 0.056, 1.05
No. of reflections2342
No. of parameters167
H-atom treatmentH atoms treated by a mixture of independent and constrained refinement
Δρmax, Δρmin (e Å−3)0.19, −0.15
Absolute structureFlack x determined using 940 quotients [(I +)−(I )]/[(I +)+(I )] (Parsons et al., 2013)
Absolute structure parameter0.006 (9)

Computer programs: APEX2 and SAINT (Bruker, 2014 ▸), SHELXT2014 (Sheldrick, 2015a ▸), SHELXL2016 (Sheldrick, 2015b ▸), Mercury (Macrae et al., 2008 ▸), DIAMOND (Brandenburg, 2006 ▸), GOLD (Chen, 2015 ▸), MOPAC (Stewart, 2013 ▸), Crystal Explorer (Wolff et al., 2012 ▸), publCIF (Westrip, 2010 ▸) and enCIFer (Allen et al., 2004 ▸).

Crystal structure: contains datablock(s) I, Global. DOI: 10.1107/S2056989017005461/su5363sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989017005461/su5363Isup2.hkl Click here for additional data file. Supporting information file. DOI: 10.1107/S2056989017005461/su5363Isup3.cml CCDC reference: 1543340 Additional supporting information: crystallographic information; 3D view; checkCIF report
C10H9ClN4OSDx = 1.498 Mg m3
Mr = 268.72Mo Kα radiation, λ = 0.71073 Å
Orthorhombic, P212121Cell parameters from 9936 reflections
a = 6.2584 (1) Åθ = 3.0–40.9°
b = 10.1734 (2) ŵ = 0.48 mm1
c = 18.7183 (3) ÅT = 200 K
V = 1191.78 (4) Å3Prism, yellow
Z = 40.46 × 0.16 × 0.12 mm
F(000) = 552
Bruker APEXII CCD area detector diffractometer2295 reflections with I > 2σ(I)
Radiation source: fine-focus sealed X-ray tube, Bruker APEXII CCDRint = 0.013
φ and ω scansθmax = 26.0°, θmin = 2.2°
Absorption correction: multi-scan (SADABS; Bruker, 2014)h = −7→5
Tmin = 0.697, Tmax = 0.749k = −12→12
10426 measured reflectionsl = −23→23
2342 independent reflections
Refinement on F2Secondary atom site location: difference Fourier map
Least-squares matrix: fullHydrogen site location: mixed
R[F2 > 2σ(F2)] = 0.020H atoms treated by a mixture of independent and constrained refinement
wR(F2) = 0.056w = 1/[σ2(Fo2) + (0.0338P)2 + 0.2804P] where P = (Fo2 + 2Fc2)/3
S = 1.05(Δ/σ)max = 0.001
2342 reflectionsΔρmax = 0.19 e Å3
167 parametersΔρmin = −0.15 e Å3
0 restraintsAbsolute structure: Flack x determined using 940 quotients [(I+)-(I-)]/[(I+)+(I-)] (Parsons et al., 2013)
Primary atom site location: structure-invariant direct methodsAbsolute structure parameter: 0.006 (9)
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.
xyzUiso*/Ueq
C10.4431 (3)0.63210 (18)0.56919 (9)0.0229 (4)
C20.3885 (3)0.51360 (17)0.61332 (9)0.0200 (4)
C30.5539 (3)0.41669 (18)0.59914 (9)0.0199 (4)
C40.5853 (3)0.28884 (18)0.62247 (9)0.0215 (3)
H40.4873620.2473090.6539820.026*
C50.7655 (3)0.22425 (18)0.59789 (9)0.0246 (4)
C60.9124 (3)0.2840 (2)0.55278 (10)0.0278 (4)
H61.0367940.2373370.5384760.033*
C70.8793 (3)0.4117 (2)0.52828 (10)0.0271 (4)
H70.9774190.4529020.4967170.033*
C80.6980 (3)0.47585 (18)0.55173 (9)0.0226 (4)
C9−0.0829 (3)0.58961 (18)0.70690 (9)0.0216 (4)
C10−0.2880 (3)0.4484 (2)0.78682 (11)0.0345 (4)
H10A−0.2600710.4906920.8329240.052*
H10B−0.3013500.3532510.7936920.052*
H10C−0.4211270.4830200.7666480.052*
Cl10.80561 (8)0.06052 (5)0.62274 (3)0.03753 (15)
N10.6267 (3)0.60279 (16)0.53459 (8)0.0254 (3)
H1N0.684 (4)0.652 (2)0.5082 (14)0.037 (7)*
N20.2289 (3)0.49844 (14)0.65623 (7)0.0210 (3)
N30.0946 (3)0.60072 (16)0.66389 (8)0.0236 (3)
H3N0.110 (4)0.669 (2)0.6405 (12)0.031 (6)*
N4−0.1123 (3)0.47545 (16)0.73815 (8)0.0244 (3)
H4N−0.014 (4)0.415 (3)0.7332 (13)0.040 (7)*
O10.3382 (2)0.73458 (13)0.56517 (7)0.0295 (3)
S1−0.24203 (8)0.72186 (5)0.71392 (3)0.03074 (13)
U11U22U33U12U13U23
C10.0266 (9)0.0228 (9)0.0194 (8)−0.0015 (7)−0.0011 (7)0.0016 (7)
C20.0213 (8)0.0188 (8)0.0198 (8)0.0008 (7)−0.0020 (6)0.0005 (6)
C30.0189 (8)0.0235 (9)0.0174 (7)−0.0005 (7)−0.0008 (6)−0.0016 (7)
C40.0212 (8)0.0240 (9)0.0194 (7)0.0020 (7)0.0004 (7)0.0010 (7)
C50.0249 (9)0.0249 (8)0.0241 (8)0.0059 (9)−0.0053 (7)−0.0014 (7)
C60.0201 (9)0.0358 (10)0.0275 (9)0.0053 (8)0.0005 (7)−0.0074 (8)
C70.0221 (9)0.0352 (10)0.0240 (8)−0.0047 (8)0.0051 (7)−0.0038 (8)
C80.0245 (10)0.0248 (9)0.0185 (7)−0.0041 (7)−0.0002 (7)−0.0022 (6)
C90.0178 (8)0.0240 (9)0.0231 (8)0.0004 (7)−0.0022 (7)−0.0042 (7)
C100.0261 (10)0.0391 (11)0.0382 (10)−0.0029 (9)0.0065 (9)0.0058 (9)
Cl10.0386 (3)0.0307 (3)0.0433 (3)0.0154 (2)−0.0012 (2)0.0053 (2)
N10.0305 (9)0.0239 (8)0.0219 (7)−0.0032 (7)0.0054 (6)0.0032 (6)
N20.0202 (8)0.0197 (6)0.0230 (7)0.0018 (6)−0.0012 (6)−0.0014 (5)
N30.0239 (8)0.0193 (7)0.0277 (8)0.0042 (6)0.0044 (6)0.0017 (6)
N40.0192 (8)0.0246 (8)0.0294 (8)0.0016 (7)0.0017 (6)0.0008 (6)
O10.0366 (8)0.0230 (7)0.0289 (6)0.0061 (6)−0.0009 (6)0.0066 (5)
S10.0266 (2)0.0249 (2)0.0407 (3)0.0070 (2)0.0042 (2)−0.00341 (19)
C1—O11.234 (2)C7—H70.9500
C1—N11.352 (3)C8—N11.404 (2)
C1—C21.501 (2)C9—N41.313 (2)
C2—N21.291 (2)C9—N31.376 (2)
C2—C31.454 (2)C9—S11.6792 (18)
C3—C41.386 (3)C10—N41.455 (2)
C3—C81.401 (3)C10—H10A0.9800
C4—C51.384 (3)C10—H10B0.9800
C4—H40.9500C10—H10C0.9800
C5—C61.388 (3)N1—H1N0.79 (3)
C5—Cl11.7475 (19)N2—N31.345 (2)
C6—C71.393 (3)N3—H3N0.83 (3)
C6—H60.9500N4—H4N0.87 (3)
C7—C81.381 (3)
O1—C1—N1127.53 (18)C7—C8—N1128.59 (18)
O1—C1—C2126.21 (17)C3—C8—N1109.59 (16)
N1—C1—C2106.26 (16)N4—C9—N3116.50 (16)
N2—C2—C3125.68 (16)N4—C9—S1126.19 (14)
N2—C2—C1127.93 (16)N3—C9—S1117.30 (13)
C3—C2—C1106.39 (15)N4—C10—H10A109.5
C4—C3—C8120.74 (17)N4—C10—H10B109.5
C4—C3—C2132.84 (17)H10A—C10—H10B109.5
C8—C3—C2106.41 (16)N4—C10—H10C109.5
C5—C4—C3117.17 (17)H10A—C10—H10C109.5
C5—C4—H4121.4H10B—C10—H10C109.5
C3—C4—H4121.4C1—N1—C8111.32 (16)
C4—C5—C6122.28 (18)C1—N1—H1N123.1 (19)
C4—C5—Cl1118.75 (15)C8—N1—H1N125.5 (19)
C6—C5—Cl1118.95 (15)C2—N2—N3117.21 (15)
C5—C6—C7120.64 (18)N2—N3—C9120.21 (15)
C5—C6—H6119.7N2—N3—H3N121.4 (17)
C7—C6—H6119.7C9—N3—H3N118.2 (17)
C8—C7—C6117.32 (17)C9—N4—C10123.53 (17)
C8—C7—H7121.3C9—N4—H4N118.4 (17)
C6—C7—H7121.3C10—N4—H4N117.8 (17)
C7—C8—C3121.81 (18)
O1—C1—C2—N2−2.4 (3)C6—C7—C8—N1−179.15 (17)
N1—C1—C2—N2178.37 (18)C4—C3—C8—C7−2.1 (3)
O1—C1—C2—C3178.15 (18)C2—C3—C8—C7178.33 (16)
N1—C1—C2—C3−1.04 (19)C4—C3—C8—N1177.97 (16)
N2—C2—C3—C42.7 (3)C2—C3—C8—N1−1.55 (19)
C1—C2—C3—C4−177.88 (19)O1—C1—N1—C8−179.07 (18)
N2—C2—C3—C8−177.86 (17)C2—C1—N1—C80.1 (2)
C1—C2—C3—C81.57 (19)C7—C8—N1—C1−178.94 (18)
C8—C3—C4—C51.1 (2)C3—C8—N1—C10.9 (2)
C2—C3—C4—C5−179.57 (18)C3—C2—N2—N3178.33 (16)
C3—C4—C5—C61.1 (3)C1—C2—N2—N3−1.0 (3)
C3—C4—C5—Cl1−177.22 (13)C2—N2—N3—C9177.74 (16)
C4—C5—C6—C7−2.3 (3)N4—C9—N3—N2−0.8 (2)
Cl1—C5—C6—C7176.06 (14)S1—C9—N3—N2179.76 (13)
C5—C6—C7—C81.2 (3)N3—C9—N4—C10178.17 (17)
C6—C7—C8—C31.0 (3)S1—C9—N4—C10−2.4 (3)
D—H···AD—HH···AD···AD—H···A
N3—H3N···O10.83 (2)2.12 (3)2.756 (2)134 (2)
N1—H1N···O1i0.79 (2)2.04 (3)2.824 (2)175 (2)
N4—H4N···S1ii0.88 (3)2.72 (3)3.518 (2)152 (2)
C6—H6···Cgiii0.952.613.410 (2)142
  11 in total

Review 1.  Beware of docking!

Authors:  Yu-Chian Chen
Journal:  Trends Pharmacol Sci       Date:  2014-12-24       Impact factor: 14.819

2.  Crystal structural studies of changes in the native dinuclear iron center of ribonucleotide reductase protein R2 from mouse.

Authors:  Kari R Strand; Solveig Karlsen; Matthias Kolberg; Asmund Kjendseth Røhr; Carl Henrik Görbitz; K Kristoffer Andersson
Journal:  J Biol Chem       Date:  2004-08-17       Impact factor: 5.157

3.  Synthesis and evaluation of isatins and thiosemicarbazone derivatives against cruzain, falcipain-2 and rhodesain.

Authors:  Idan Chiyanzu; Elizabeth Hansell; Jiri Gut; Philip J Rosenthal; James H McKerrow; Kelly Chibale
Journal:  Bioorg Med Chem Lett       Date:  2003-10-20       Impact factor: 2.823

4.  Optimization of parameters for semiempirical methods VI: more modifications to the NDDO approximations and re-optimization of parameters.

Authors:  James J P Stewart
Journal:  J Mol Model       Date:  2012-11-28       Impact factor: 1.810

5.  Ribonucleotide reductase inhibition by metal complexes of Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone): a combined experimental and theoretical study.

Authors:  Ana Popović-Bijelić; Christian R Kowol; Maria E S Lind; Jinghui Luo; Fahmi Himo; Eva A Enyedy; Vladimir B Arion; Astrid Gräslund
Journal:  J Inorg Biochem       Date:  2011-07-31       Impact factor: 4.155

6.  (Z)-2-(5-Chloro-2-oxoindolin-3-yl-idene)-N-methyl-hydrazinecarbothio-amide.

Authors:  Amna Qasem Ali; Naser Eltaher Eltayeb; Siang Guan Teoh; Abdussalam Salhin; Hoong-Kun Fun
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-03-07

7.  2-(5-Chloro-2-oxoindolin-3-yl-idene)hydrazinecarbo-thio-amide.

Authors:  Viviane Conceição Duarte de Bittencourt; Juliano Rosa de Menezes Vicenti; Jecika Maciel Velasques; Priscilla Jussiane Zambiazi; Vanessa Carratu Gervini
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-12-14

8.  SHELXT - integrated space-group and crystal-structure determination.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A Found Adv       Date:  2015-01-01       Impact factor: 2.290

9.  Crystal structure refinement with SHELXL.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr C Struct Chem       Date:  2015-01-01       Impact factor: 1.172

10.  Isatin thiazoline hybrids as dual inhibitors of HIV-1 reverse transcriptase.

Authors:  Rita Meleddu; Simona Distinto; Angela Corona; Enzo Tramontano; Giulia Bianco; Claudia Melis; Filippo Cottiglia; Elias Maccioni
Journal:  J Enzyme Inhib Med Chem       Date:  2016-10-21       Impact factor: 5.051

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.